kr55.85
0.00% today
Stockholm, Dec 04, 05:29 pm CET
ISIN
SE0000163628
Symbol
EKTA B

Elekta AB Stock price

kr55.85
+9.33 20.06% 1M
+6.13 12.33% 6M
-5.30 8.67% YTD
-6.50 10.43% 1Y
-6.35 10.21% 3Y
-52.91 48.65% 5Y
-16.74 23.06% 10Y
+39.74 246.71% 20Y
Stockholm, Closing price Thu, Dec 04 2025
+0.00 0.00%
ISIN
SE0000163628
Symbol
EKTA B

Key metrics

Basic
Market capitalization
kr21.3b
Enterprise Value
kr26.3b
Net debt
kr5.0b
Cash
kr2.6b
Shares outstanding
382.1m
Valuation (TTM | estimate)
P/E
73.5 | 16.5
P/S
1.2 | 1.2
EV/Sales
1.5 | 1.5
EV/FCF
13.3
P/B
2.5
Dividends
DPS
kr2.40
Yield 1Y | 5Y
4.3% | 2.2%
Growth 1Y | 5Y
0.0% | 6.1%
Payout 1Y | 3Y
70.4% | 80.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
kr17.6b | kr17.7b
EBITDA
kr3.6b | kr3.4b
EBIT
kr1.8b | kr2.0b
Net Income
kr292.0m | kr1.3b
Free Cash Flow
kr2.0b
Growth (TTM | estimate)
Revenue
-0.9% | -1.8%
EBITDA
35.9% | -36.1%
EBIT
-9.2% | 0.7%
Net Income
-70.8% | 444.3%
Free Cash Flow
239.4%
Margin (TTM | estimate)
Gross
38.2%
EBITDA
20.4% | 19.2%
EBIT
10.3%
Net
1.7% | 7.3%
Free Cash Flow
11.2%
Financial Health
Equity Ratio
30.4%
Return on Equity
2.7%
ROCE
11.6%
ROIC
5.6%
Debt/Equity
0.9
More
EPS
kr0.8
FCF per Share
kr5.2
Short interest
-
Employees
5k
Rev per Employee
kr4.0m
Show more

Is Elekta AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Elekta AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Elekta AB forecast:

3x Buy
16%
7x Hold
37%
9x Sell
47%

Analyst Opinions

19 Analysts have issued a Elekta AB forecast:

Buy
16%
Hold
37%
Sell
47%

Financial data from Elekta AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '25
+/-
%
17,567 17,567
1% 1%
100%
- Direct Costs 10,862 10,862
3% 3%
62%
6,705 6,705
3% 3%
38%
- Selling and Administrative Expenses 3,011 3,011
3% 3%
17%
- Research and Development Expense 27 27
97% 97%
0%
3,576 3,576
36% 36%
20%
- Depreciation and Amortization 1,759 1,759
178% 178%
10%
EBIT (Operating Income) EBIT 1,817 1,817
9% 9%
10%
Net Profit 292 292
71% 71%
2%

In millions SEK.

Don't miss a Thing! We will send you all news about Elekta AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Jonas Bolander
Employees 4,541
Founded 1972
Website www.elekta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today